LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients. (Q46436094)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 August 2008
edit
Language Label Description Also known as
English
LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients.
scientific article published on 9 August 2008

    Statements

    LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit